Injective price prediction: Is the rally sustainable? INJ climbs 7.11% to $5.20

Traders Union
All News
Crypto News
Injective surges 7.11% to $5.20 today

Highlights

INJ rose 7.11% to $5.20, trading above its MA-20 ($4.66) and dynamic support (Kijun $5.18) but capped by MA-50 ($5.35) resistance.
Momentum indicators are mixed: strong daily MACD sell and overbought oscillators counter intraday buyer dominance, suggesting near-term upside may be exhausted.
Weekly forecast expects INJ to consolidate in a $4.95–$5.50 range, with less than 20% probability of further price increases and a bearish bias prevailing.

Mixed momentum signals as overbought levels clash with trend strength

Momentum readings are mixed: while MACD on the daily shows a strong sell, ADX at 30.44 points to trend strength but with a sell bias. The market is overbought on both Stoch RSI and CCI, and RSI is neutral-bullish near 50. BBP indicates buyers dominate intraday momentum, supporting today's 7.11% rise to $5.20. There was no opening gap (open $4.91 vs previous close $4.85), and after an early push, price now sits near the top of today’s range, showing high volatility with persistent strength after the open. Divergence in oscillators and momentum suggests near-term upside may be exhausted and calls for caution as short-term momentum and intraday action are not fully confirmed by broader daily signals.

Sideways consolidation expected as bearish signals cap upside

For the next five trading days, the adjusted weekly forecast range is $4.95 – $5.50, straddling current prices with a sideways bias. The probability of further price increases is very low (less than 20%), making a decline more likely based on persistent bearish weekly signals across the MA-50, MACD, ADX, and weekly RSI. The baseline scenario is for INJ to consolidate between nearby support ($4.95) and resistance ($5.35 – $5.50). A bullish outcome would require a sustained breakout above $5.50 resistance, opening room for further gains. Conversely, a bearish scenario unfolds if the price falls below $4.95, risking deeper correction toward lower support levels.

Anton Kharitonov, leading expert at Traders Union, sees INJ’s short-term momentum as fragile and unconfirmed by broader trends. He believes persistent resistance near $5.35 – $5.50 and overbought conditions limit further upside, while technical signals point to a likely consolidation or decline. Immediate support at $4.95 is key to the downside scenario. "Unless INJ can break and hold above $5.50, my base case remains sideways to lower — I stay defensive here."

Previously it was reported that Injective is exhibiting short-term strength by holding above its 20-day moving average, but remains under longer-term moving averages, with mixed daily momentum and bearish weekly indicators prevailing. The token is expected to consolidate within a defined range as intraday buyer pressure diverges from broader bearish signals, with resistance near $5.38 and support at $5.18.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.